Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Dressman

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Journal of Pharmaceutical Sciences|January 17, 2024
Silicon-Based Piezo Micropumps Enable Fully Flexible Drug Delivery PatternsDavid Plano, Sebastian Kibler, Niklas Rudolph, et al.
Journal of Pharmaceutical Sciences|June 22, 2024
A Stratified Analysis of Supersaturation and Precipitation Effects Based on the Refined Developability Classification System (rDCS)Kristian Beran, Eline Hermans, René Holm, et al.
AAPS Pharmscitech|August 15, 2003
FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage formsMartin Siewert, Jennifer Dressman, Cynthia K Brown, et al.
Journal of Pharmaceutical Sciences|October 7, 2024
Using the refined Developability Classification System (rDCS) to guide the design of oral formulationsKristian Beran, Eline Hermans, René Holm, et al.
Journal of Pharmaceutical Sciences|December 26, 2024
Advantages of the refined developability classification system in early discoveryKristian Beran, Jennifer Dressman, Eline Hermans, et al.
Pharmaceutics|July 29, 2023
Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS)Kristian Beran, Eline Hermans, René Holm, et al.
Pharmaceutics|November 5, 2020
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of FlurbiprofenIoannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Masoud Jamei, et al.
The Journal of Pharmacy and Pharmacology|January 25, 2003
Biorelevant dissolution testing of St John's wort productsKerstin Westerhoff, Astrid Kaunzinger, Mario Wurglics, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 4, 2015
In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test mediaConstantinos Markopoulos, Cord J Andreas, Maria Vertzoni, et al.
Journal of Pharmaceutical Sciences|October 1, 2021
Biorelevant in vitro Tools and in silico Modeling to Assess pH-Dependent Drug-drug Interactions for Salts of Weak Acids: Case Example Potassium RaltegravirDomagoj Segregur, James Mann, Andrea Moir, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Journal of Pharmaceutical Sciences|January 17, 2024
Silicon-Based Piezo Micropumps Enable Fully Flexible Drug Delivery PatternsDavid Plano, Sebastian Kibler, Niklas Rudolph, et al.
Journal of Pharmaceutical Sciences|June 22, 2024
A Stratified Analysis of Supersaturation and Precipitation Effects Based on the Refined Developability Classification System (rDCS)Kristian Beran, Eline Hermans, René Holm, et al.
AAPS Pharmscitech|August 15, 2003
FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage formsMartin Siewert, Jennifer Dressman, Cynthia K Brown, et al.
Journal of Pharmaceutical Sciences|October 7, 2024
Using the refined Developability Classification System (rDCS) to guide the design of oral formulationsKristian Beran, Eline Hermans, René Holm, et al.
Journal of Pharmaceutical Sciences|December 26, 2024
Advantages of the refined developability classification system in early discoveryKristian Beran, Jennifer Dressman, Eline Hermans, et al.
Pharmaceutics|July 29, 2023
Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS)Kristian Beran, Eline Hermans, René Holm, et al.
Pharmaceutics|November 5, 2020
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of FlurbiprofenIoannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Masoud Jamei, et al.
The Journal of Pharmacy and Pharmacology|January 25, 2003
Biorelevant dissolution testing of St John's wort productsKerstin Westerhoff, Astrid Kaunzinger, Mario Wurglics, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 4, 2015
In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test mediaConstantinos Markopoulos, Cord J Andreas, Maria Vertzoni, et al.
Journal of Pharmaceutical Sciences|October 1, 2021
Biorelevant in vitro Tools and in silico Modeling to Assess pH-Dependent Drug-drug Interactions for Salts of Weak Acids: Case Example Potassium RaltegravirDomagoj Segregur, James Mann, Andrea Moir, et al.
Pageof 13